About this trial
To evaluate the patient-level early diagnostic performance of high-penetration super-resolution transcranial ultrasound for identifying intracranial metallic targets, and to further assess clip-level detection, localization, agreement, and its complementary value to routine postoperative imaging.This study does not alter routine clinical treatment. All participants will undergo standardized high-penetration super-resolution transcranial ultrasound within 3 hours after surgery. Postoperative CT is mandatory for all participants; CTA or other routine postoperative imaging will be obtained only when clinically indicated.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-85 years;
Positive group: patients undergoing intracranial aneurysm clipping with implanted metallic clips; negative control group: postoperative craniotomy patients without implanted clips;
Ability to complete transcranial ultrasound within 3 hours after surgery;
Availability of postoperative CT;
Disqualifiers
Inability to complete standardized transcranial ultrasound;
Missing postoperative CT;
Inability to establish the composite reference standard;
Presence of non-study-related metallic materials that may substantially interfere with target identification;
Trial population
Positive group: standardized high-penetration super-resolution transcranial ultrasound within 3 hours after surgery, plus routine postoperative CT and CTA/other routine imaging when clinically indicated. Negative control group: standardized high-penetration super-resolution transcranial ultrasound within 3 hours after surgery, plus routine postoperative CT.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Patient-level sensitivity for identifying the presence or absence of intracranial metallic targets
Patient-level specificity for identifying the presence or absence of intracranial metallic targets
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: